BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30900614)

  • 1. Magnetic resonance imaging radiomic feature analysis of radiation-induced femoral head changes in prostate cancer radiotherapy.
    Abdollahi H; Mahdavi SR; Shiri I; Mofid B; Bakhshandeh M; Rahmani K
    J Cancer Res Ther; 2019 Mar; 15(Supplement):S11-S19. PubMed ID: 30900614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
    Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
    Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI Radiomic Analysis of IMRT-Induced Bladder Wall Changes in Prostate Cancer Patients: A Relationship with Radiation Dose and Toxicity.
    Abdollahi H; Tanha K; Mofid B; Razzaghdoust A; Saadipoor A; Khalafi L; Bakhshandeh M; Mahdavi SR
    J Med Imaging Radiat Sci; 2019 Jun; 50(2):252-260. PubMed ID: 31176433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal wall MRI radiomics in prostate cancer patients: prediction of and correlation with early rectal toxicity.
    Abdollahi H; Mahdavi SR; Mofid B; Bakhshandeh M; Razzaghdoust A; Saadipoor A; Tanha K
    Int J Radiat Biol; 2018 Sep; 94(9):829-837. PubMed ID: 29969358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
    Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
    J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in ADC and T2-weighted MRI-derived radiomic features in patients treated with focal salvage HDR prostate brachytherapy for local recurrence after previous external-beam radiotherapy.
    Lee SL; Ravi A; Morton G; Loblaw A; Tseng CL; Haider M; Murgic J; Nicolae A; Semple M; Chung HT
    Brachytherapy; 2019; 18(5):567-573. PubMed ID: 31126856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
    J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial T2-Weighted Magnetic Resonance Images Acquired on a 1.5 Tesla Magnetic Resonance Linear Accelerator Reveal Radiomic Feature Variation in Organs at Risk: An Exploratory Analysis of Novel Metrics of Tissue Response in Prostate Cancer.
    Lorenz JW; Schott D; Rein L; Mostafaei F; Noid G; Lawton C; Bedi M; Li XA; Schultz CJ; Paulson E; Hall WA
    Cureus; 2019 Apr; 11(4):e4510. PubMed ID: 31259119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features.
    Bernatz S; Ackermann J; Mandel P; Kaltenbach B; Zhdanovich Y; Harter PN; Döring C; Hammerstingl R; Bodelle B; Smith K; Bucher A; Albrecht M; Rosbach N; Basten L; Yel I; Wenzel M; Bankov K; Koch I; Chun FK; Köllermann J; Wild PJ; Vogl TJ
    Eur Radiol; 2020 Dec; 30(12):6757-6769. PubMed ID: 32676784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?
    Donati OF; Jung SI; Vargas HA; Gultekin DH; Zheng J; Moskowitz CS; Hricak H; Zelefsky MJ; Akin O
    Radiology; 2013 Aug; 268(2):440-50. PubMed ID: 23481164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218).
    Gugliandolo SG; Pepa M; Isaksson LJ; Marvaso G; Raimondi S; Botta F; Gandini S; Ciardo D; Volpe S; Riva G; Rojas DP; Zerini D; Pricolo P; Alessi S; Petralia G; Summers PE; Mistretta FA; Luzzago S; Cattani F; De Cobelli O; Cassano E; Cremonesi M; Bellomi M; Orecchia R; Jereczek-Fossa BA
    Eur Radiol; 2021 Feb; 31(2):716-728. PubMed ID: 32852590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Zhou X; Yi Y; Liu Z; Cao W; Lai B; Sun K; Li L; Zhou Z; Feng Y; Tian J
    Ann Surg Oncol; 2019 Jun; 26(6):1676-1684. PubMed ID: 30887373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haralick textural features on T
    Gnep K; Fargeas A; Gutiérrez-Carvajal RE; Commandeur F; Mathieu R; Ospina JD; Rolland Y; Rohou T; Vincendeau S; Hatt M; Acosta O; de Crevoisier R
    J Magn Reson Imaging; 2017 Jan; 45(1):103-117. PubMed ID: 27345946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance radiomic feature performance in pulmonary nodule classification and impact of segmentation variability on radiomics.
    Koo CW; Kline TL; Yoon JH; Vercnocke AJ; Johnson MP; Suman G; Lu A; Larson NB
    Br J Radiol; 2022 Dec; 95(1140):20220230. PubMed ID: 36367095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the most significant magnetic resonance imaging (MRI) radiomic features in oncological patients with vertebral bone marrow metastatic disease: a feasibility study.
    Filograna L; Lenkowicz J; Cellini F; Dinapoli N; Manfrida S; Magarelli N; Leone A; Colosimo C; Valentini V
    Radiol Med; 2019 Jan; 124(1):50-57. PubMed ID: 30191445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study.
    Hu L; Zhou DW; Fu CX; Benkert T; Jiang CY; Li RT; Wei LM; Zhao JG
    Eur Radiol; 2021 Mar; 31(3):1760-1769. PubMed ID: 32935192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images.
    Zhang Z; Yang J; Ho A; Jiang W; Logan J; Wang X; Brown PD; McGovern SL; Guha-Thakurta N; Ferguson SD; Fave X; Zhang L; Mackin D; Court LE; Li J
    Eur Radiol; 2018 Jun; 28(6):2255-2263. PubMed ID: 29178031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancer.
    Bologna M; Calareso G; Resteghini C; Sdao S; Montin E; Corino V; Mainardi L; Licitra L; Bossi P
    NMR Biomed; 2022 Apr; 35(4):e4265. PubMed ID: 32009265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of renal function after conformal radiotherapy and intensity-modulated radiotherapy by functional 1H-MRI and 23Na-MRI.
    Haneder S; Michaely HJ; Schoenberg SO; Konstandin S; Schad LR; Siebenlist K; Wertz H; Wenz F; Lohr F; Boda-Heggemann J
    Strahlenther Onkol; 2012 Dec; 188(12):1146-54. PubMed ID: 23111472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.